表紙
市場調査レポート

世界のマイクロアレイ市場

Microarray Markets

発行 TriMark Publications 商品コード 72211
出版日 ページ情報 英文 202 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=102.18円で換算しております。
Back to Top
世界のマイクロアレイ市場 Microarray Markets
出版日: 2013年08月01日 ページ情報: 英文 202 Pages
概要

当レポートでは、世界のマイクロアレイ市場について、プロテインおよびDNAマイクロアレイ市場を中心に分析しており、創薬、病気診断および病気モニタリング目的でDNA・タンパク質を検出する病院、診療所、商業ラボおよび研究機関で利用されるさまざまなマイクロアレイプラットフォーム・技術の調査、主要企業のプロファイル、販売予測・市場シェアデータを示した詳細な図表などを提供しており、概略下記の内容でお届けいたします。

第1章 概要

第2章 マイクロアレイの商業機会

  • マイクロアレイ技術が普及している市場
  • マイクロアレイ市場の分析
  • 市場成長促進因子
  • 市場成長阻害因子
  • 主要企業とその市場シェア
  • マイクロアレイの戦略的動向と競合情勢
  • マーケティングと流通

第3章 マイクロアレイの概要

  • 歴史
  • ゲノミクスとプロテオミクス
  • マイクロアレイの一般原理
    • DNAマイクロアレイ
  • タンパク質マイクロアレイ
  • 組織マイクロアレイ
  • 低複雑度マイクロアレイ
  • 炭水化物マイクロアレイ

第4章 DNAマイクロアレイ

  • DNAマイクロアレイの技術プラットフォーム
  • マイクロアレイの種類とアプリケーション
  • 研究者がDNAマイクロアレイを利用する理由
  • DNAマイクロアレイ技術の適用を困難にする要因
  • DNAマイクロアレイソフトウェアの主要属性
  • 病気の治療におけるマイクロアレイ技術
  • DNAマイクロアレイの商業化
  • DNAマイクロアレイ技術の将来の方向性
  • 新しいマイクロアレイ動向
  • 新しいマイクロアレイアプリケーション
  • DNAマイクロアレイ技術の将来の方向性
  • マイクロアレイベースのアプリケーション開発における要点
  • DNAマイクロアレイの競合環境

第5章  タンパク質マイクロアレイ

  • タンパク質マイクロアレイの種類
  • マイクロアレイコンテンツにとっての重要要素
  • マイクロアレイの利用における主要調査結果
  • メリット・成長牽引因子
  • 商業化における障壁
  • タンパク質マイクロアレイ技術の主な実験的パラメーター
  • 研究者がタンパク質マイクロアレイを利用する理由
  • タンパク質マイクロアレイ技術の導入要因
  • マイクロアレイスライド・製品の主要サプライヤー
  • 販売意思決定への影響因子
  • タンパク質マイクロアレイ技術における将来の革新
  • タンパク質アレイ市場の分析

第6章 現在のDNAマイクロアレイ

  • 主要企業
  • 高成長アプリケーション
  • DNAマイクロアレイ技術における革新
  • 次世代シーケンシングはDNAマイクロアレイ技術に置き換わるか?

第7章 現在のタンパク質マイクロアレイ

  • タンパク質プロファイリングマイクロアレイ:抗体アレイ
  • タンパク質プロファイリングマイクロアレイ:逆相マイクロアレイ
  • 多重サンドイッチマイクロアレイ:平面
  • 多重サンドイッチイムノアッセイ:ビーズベース
  • タンパク質の機能研究のためのマイクロアレイ
  • 専門家および高成長アプリケーション
  • アプタマーアレイ
  • 無細胞アレイ
  • タンパク質ナノアレイ

第8章 技術

  • マイクロアレイの製造
  • 2D vs 3D技術
  • 基板・表面化学
  • 次世代マイクロアレイ
  • 検出法
  • 機器
  • 遺伝子発現のデータ管理・インフォマティクス
  • ソフトウェア・データ分析

第9章 ラボオンチップ技術

  • ラボオンチップのイントロダクション
  • ラボオンチップ技術
  • ラボオンチップ技術のアプリケーション
  • ラボオンチップ技術のメリット
  • 広範な導入の障壁
  • 特許ポートフォリオ
  • ラボオンチップ技術の動向・展望
  • ラボオンチップ産業の主要企業
  • ラボオンチップ市場の分析

第10章 アプリケーション

  • 遺伝子発現におけるDNAマイクロアレイ
  • SNP分析におけるDNAマイクロアレイ
  • 癌におけるDNAマイクロアレイ
  • タンパク質マイクロアレイ
  • 標的/バイオマーカーの発見
  • 創薬・医薬品開発(遺伝子・タンパク質マイクロアレイ)
  • 臨床診断(遺伝子・タンパク質マイクロアレイ)
  • RNAマイクロアレイ
  • オリゴマイクロアレイ
  • イーストマイクロアレイ
  • 抗体アレイ
  • トキシコゲノミクス用アレイ
  • 微生物アプリケーション
  • 微生物遺伝子型決定製品市場

第11章 競合情勢

  • 商業マイクロアレイ市場
  • 部門の整理統合
  • 規制事項
  • 法的事項
  • 特許
  • 合併、買収および合意

第12章 企業プロファイル

図表リスト

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: TMRMICA13-0801

Abstract

Microarray technologies multiplex and miniaturize the analysis of tens of thousands of molecules for a variety of assays, including drug binding, molecular interactions, enzyme activity and pathway identification. These microarrays, which include DNA microarrays, protein microarrays, tissue microarrays, low complexity microarrays and carbohydrate microarrays, are excellent tools for gene expression profiling, biomarker profiling and diagnostics. Pharmaceutical and biotechnology researchers use microarrays to streamline drug target identification, selection, validation and predictive testing. Rapid growth in the clinical research and diagnostic devices markets holds great potential for applications of microarray technology, including basic research, clinical trials and diagnostic devices. This TriMark Publications reports describes the specific segment of the microarray market aimed at the analysis of proteins and DNA. It examines various microarray platforms and the technologies that are utilized in hospitals, clinics, commercial laboratories and research institutions to detect DNA and proteins for the purpose of drug discovery, disease diagnosis and disease monitoring. This report also examines companies that are actively developing and marketing microarray instrumentation or microarray biochips. Detailed tables and charts with sales forecasts and marketshare data are also included.

Table of Contents

1. Overview

  • 1.1. Statement of Report
  • 1.2. Scope of the Report
  • 1.3. Objectives
  • 1.4. Methodology
  • 1.5. Executive Summary

2. The Commercial Opportunity for Microarrays

  • 2.1. Markets Served by Microarray Technologies
    • 2.1.1. Basic Research Markets
    • 2.1.2. Translational Medicine Markets
    • 2.1.3. Molecular Diagnostic Markets
    • 2.1.4. Specialized/Applied Markets
  • 2.2. Microarray Market Analysis
  • 2.3. Market Drivers
  • 2.4. Market Restraints for Microarrays
  • 2.5. Key Players and Market Share for Major Players
  • 2.6. Strategic Trends and Competitive Landscape for Microarrays
  • 2.7. Marketing and Distribution

3. Microarray Overview

  • 3.1. History of Microarrays
  • 3.2. Genomics and Proteomics
    • 3.2.1. Genetic Variability and Disease
  • 3.3. General Theory of Microarrays
    • 3.3.1. DNA Microarrays
  • 3.4. Protein Microarrays
  • 3.5. Tissue Microarrays
  • 3.6. Low Complexity Microarrays
  • 3.7. Carbohydrate Microarrays

4. DNA Microarrays

  • 4.1. DNA Microarray Technology Platforms
    • 4.1.1. Microarray Technology
    • 4.1.2. DNA Microarrays Experimental Design
  • 4.2. Types of Microarrays and Their Applications
    • 4.2.1. Common Microarray Applications
  • 4.3. Reasons Why Researchers Utilize DNA Microarrays
  • 4.4. Factors for Difficulties Applying DNA Microarray Technology
  • 4.5. Key Attributes of DNA Microarray Software
  • 4.6. Microarray Technology in Treating Disease
    • 4.6.1. High-Throughput Array Technology and Cancer
    • 4.6.2. Microarray-Based Commercial Genotyping Activity
  • 4.7. Commercialization of DNA Microarrays
  • 4.8. Future Directions for DNA Microarray Technology
    • 4.8.1. Microarrays vs. Next-Generation Sequencing
  • 4.9. Emerging Microarray Trends
  • 4.10. Emerging Microarray Applications
  • 4.11. Key Points for Developing Microarray-Based Applications
  • 4.12. Competitive Landscape for DNA Microarrays

5. Protein Microarrays

  • 5.1. Types of Protein Microarrays
    • 5.1.1. Forward Phase Microarrays
    • 5.1.2. Reverse Phase Microarrays
    • 5.1.3. Peptoid Arrays
    • 5.1.4. Nucleic Acid Programmable Protein Arrays (NAPPA)
    • 5.1.5. Antibody Microarrays
    • 5.1.6. Classifying Protein Microarrays Based on Application
  • 5.2. Critical Factors for Microarray Content
  • 5.3. Key Findings on the Use of Microarrays
  • 5.4. Advantages and Drivers
  • 5.5. Limitations and Barriers to Commercialization
  • 5.6. Key Experimental Parameters of Protein Microarray Technology
  • 5.7. Reasons Why Researchers Utilize Protein Microarrays
  • 5.8. Factors for Adoption of Protein Microarray Technology
  • 5.9. Top Suppliers of Protein Microarray Slides and Products
  • 5.10. Factors that Influence Sale Decisions
  • 5.11. Future Innovations in Protein Microarray Technology
  • 5.12. Protein Arrays Market Analysis

6. Current DNA Microarrays

  • 6.1. Key Players
  • 6.2. High Growth Applications
    • 6.2.1. Microarray-Based Commercial Genotyping Activity
    • 6.2.2. Location Analysis
    • 6.2.3. Tiling Arrays
    • 6.2.4. Epigenetic Mapping Arrays
  • 6.3. Innovations in DNA Microarray Technology
  • 6.4. Will Next-Generation Sequencing Replace DNA Microarray Technology?

7. Current Protein Microarrays

  • 7.1. Protein Profiling Microarrays Antibody Arrays
  • 7.2. Protein Profiling Microarrays Reverse Phase Microarrays
  • 7.3. Multiplex Sandwich Microarrays Planar
  • 7.4. Multiplex Sandwich Immunoassays Bead Based
  • 7.5. Microarrays for Protein Function Studies
  • 7.6. Specialized and High Growth Applications
    • 7.6.1. Cytokine Arrays
    • 7.6.2. Whole Proteome Arrays
  • 7.7. Aptamer Arrays
  • 7.8. Cell-Free Arrays
  • 7.9. Protein Nanoarrays

8. Technology

  • 8.1. Production of Microarrays
  • 8.2. 2D versus 3D Technology
  • 8.3. Substrates and Surface Chemistries
  • 8.4. Next-Generation Microarrays
  • 8.5. Detection Methods
  • 8.6. Instruments
  • 8.7. Data Management and Informatics in Gene Expression
  • 8.8. Software and Data Analysis
    • 8.8.1. Supplier of DNA Microarray Analysis Software
    • 8.8.2. Satisfaction with Software Features
    • 8.8.3. Satisfaction with Software
    • 8.8.4. Supplier Factors in Software Purchase Decision
    • 8.8.5. Suppliers' Role in Improving Data Sharing for DNA Microarrays

9. Lab-on-a-Chip Technologies

  • 9.1. Introduction to Lab-on-a-Chip
  • 9.2. Lab-on-a-Chip Technology
  • 9.3. Applications for Lab-on-a-Chip Technology
  • 9.4. The Advantages of Lab-on-a-Chip Technology
  • 9.5. Barriers to Widespread Adoption
  • 9.6. Patent Portfolios
  • 9.7. Trends and Outlook for Lab-on-a-Chip Technology
  • 9.8. Key Players in Lab-on-a-Chip Industry
  • 9.9. Lab-on-a-Chip Market Analysis

10. Applications

  • 10.1. DNA Microarrays in Gene Expression
  • 10.2. DNA Microarrays in SNP Analysis
  • 10.3. DNA Microarrays in Cancer
    • 10.3.1. Cancer and Fusion Genes
  • 10.4. Protein Microarrays
    • 10.4.1. Cytokine Applications
    • 10.4.2. Protein Function
    • 10.4.3. Protein Microarrays in Personalized Medicine
    • 10.4.4. Protein-Protein Interactions
  • 10.5. Target/Biomarker Discovery
  • 10.6. Drug Discovery and Development (Gene and Protein Microarrays)
  • 10.7. Clinical Diagnostics (Gene and Protein Microarrays)
  • 10.8. RNA Microarrays
  • 10.9. Oligo Microarrays
  • 10.10. Yeast Microarrays
  • 10.11. Antibody Arrays
  • 10.12. Arrays for Toxicogenomics
  • 10.13. Microbial Applications
  • 10.14. The Market for Microbial Genotyping Products

11. Competitive Landscape

  • 11.1. The Commercial Microarray Market
  • 11.2. Sector Consolidation
  • 11.3. Regulatory Matters
  • 11.4. Legal Matters
  • 11.5. Intellectual Property
  • 11.6. Mergers, Acquisitions and Agreements

12. Company Profiles

  • 12.1. Affymetrix
  • 12.2. Agilent Technologies, Inc.
  • 12.3. Arrayit Corporation
  • 12.4. Applied Microarrays
  • 12.5. AutoGenomics, Inc.
  • 12.6. AyoxxA
  • 12.7. BioCat GmbH
  • 12.8. BioChain, Inc.
  • 12.9. BioForce Nanosciences, Inc.
  • 12.10. BioGenex
  • 12.11. Biomedical Diagnostics (BMD)
  • 12.12. Biolog, Inc.
  • 12.13. bioM_rieux SA
  • 12.14. Biometrix Technology, Inc.
  • 12.15. Bio-Rad Laboratories
  • 12.16. Cancer Genetics, Inc.
  • 12.17. Cepheid, Inc.
  • 12.18. Clontech Laboratories, Inc.
  • 12.19. CombiMatrix Corporation
  • 12.20. CYBRDI
  • 12.21. DiagnoSwiss SA
  • 12.22. Discerna
  • 12.23. EMD Millipore
  • 12.24. Eurogentec
  • 12.25. Exiqon
  • 12.26. Fluidigm Corporation
  • 12.27. Gamida for Life Group
  • 12.28. GE Healthcare
  • 12.29. GGrace Bio-Labs
  • 12.30. Greiner Bio-One
  • 12.31. Healthcare IT, Inc.
  • 12.32. Great Basin Corporation
  • 12.33. Gyros AB
  • 12.34. Illumina, Inc.
  • 12.35. Imgenex Corp.
  • 12.36. Immucor
  • 12.37. InDevR
  • 12.38. Isu Abxis Co., Ltd.
  • 12.39. LC Sciences
  • 12.40. Life Technologies/Applied Biosystems (AB)/Invitrogen
  • 12.41. Lineagen, Inc.
  • 12.42. Luminex Corporation
  • 12.43. Maine Manufacturing, LLC
  • 12.44. Meso Scale Discovery
  • 12.45. Microarrays, Inc.
  • 12.46. Microbionix
  • 12.47. Mingyuan Medicare Development Company Limited
  • 12.48. MiraiBio
  • 12.49. Molecular Devices, LLC
  • 12.50. Monogram Biosciences
  • 12.51. Myriad Genetics, Inc.
  • 12.52. NextGen Sciences PLC
  • 12.53. One Lambda
  • 12.54. OriGene Technologies
  • 12.55. Orla Protein Technologies
  • 12.56. Oxford Nanopore Technologies Ltd.
  • 12.57. Oxford Gene Technology
  • 12.58. PamGene BV
  • 12.59. Partek, Inc.
  • 12.60. Pepscan
  • 12.61. Perkin Elmer, Inc.
  • 12.62. Phalanx Biotech Group
  • 12.63. PharmaSeq
  • 12.64. Platypus Technologies, LLC
  • 12.65. Protagen AG
  • 12.66. ProteoGenix
  • 12.67. ProteinOne, Inc.
  • 12.68. QIAGEN
  • 12.69. Radix BioSolutions
  • 12.70. Randox Laboratories Ltd.
  • 12.71. R&D Systems
  • 12.72. RayBiotech
  • 12.73. Roche NimbleGen, Inc.
  • 12.74. Sequenom, Inc.
  • 12.75. Sigma-Aldrich
  • 12.76. SmartBead Technologies
  • 12.77. SomaLogic
  • 12.78. SQI Diagnostics
  • 12.79. SuperBioChips Laboratories
  • 12.80. Theranostic Health, Inc.
  • 12.81. Toray Industries, Inc.
  • 12.82. Trans Genic, Inc.
  • 12.83. US Biomax
  • 12.84. Veredus Laboratories Pte Ltd.
  • 12.85. Zeptosens
  • 12.86. Zeus Scientific, Inc.
  • 12.87. Zyagen

INDEX OF FIGURES

  • Figure 2.1: Life Sciences Tools Markets, by Sector Served, 2012
  • Figure 2.2: Market Share within the Genetic Tools Market, 2012
  • Figure 2.3: Microarray Market Share, by Product Type
  • Figure 2.4: Global Market Share for Microarray Markets; by Region
  • Figure 3.1: Typical Two-Channel DNA Microarray Experiment
  • Figure 4.1: Segment of Double-Stranded DNA Showing the Base-Pair Relationship
  • Figure 5.1: Peptoid Arrays as Platforms for Biomarker Discovery
  • Figure 6.1: ChIP-on-Chip Experiment
  • Figure 6.2: The Choice between NGS and Microarrays: Rating by Application
  • Figure 7.1: Biomarker Discovery and Validation
  • Figure 7.2: Antibody Microarrays Sandwich Detection Methods
  • Figure 7.3: Cytokines and Growth Factors: Sources of Microarrays for Cytokine Research
  • Figure 8.1: Sources of Variation in Microarray Data
  • Figure 9.1: A Visual Representation of Lab-on-a-Chip and Related Technologies
  • Figure 9.2: Unit Components Making up the Lab-on-a-Chip (LOAC) System
  • Figure 9.3: Market Share of Biochips Products by Type, 2013
  • Figure 10.1: Toxicogenomics: DNA Microarrays
  • Figure 10.2: Microbial Genotyping: Applications for DNA Microarrays
  • Figure 11.1: Microarray Patents by Region, up to 2013
  • Figure 11.2: Microarray Patents by Year, up to 2013
  • Figure 2.1: Life Sciences Tools Markets, by Sector Served, 2012
  • Figure 2.2: Market Share within the Genetic Tools Market, 2012
  • Figure 2.3: Microarray Market Share, by Product Type
  • Figure 2.4: Global Market Share for Microarray Markets; by Region
  • Figure 3.1: Typical Two-Channel DNA Microarray Experiment
  • Figure 4.1: Segment of Double-Stranded DNA Showing the Base-Pair Relationship
  • Figure 5.1: Peptoid Arrays as Platforms for Biomarker Discovery
  • Figure 6.1: ChIP-on-Chip Experiment
  • Figure 6.2: The Choice between NGS and Microarrays: Rating by Application
  • Figure 7.1: Biomarker Discovery and Validation
  • Figure 7.2: Antibody Microarrays Sandwich Detection Methods
  • Figure 7.3: Cytokines and Growth Factors: Sources of Microarrays for Cytokine Research
  • Figure 8.1: Sources of Variation in Microarray Data
  • Figure 9.1: A Visual Representation of Lab-on-a-Chip and Related Technologies
  • Figure 9.2: Unit Components Making up the Lab-on-a-Chip (LOAC) System
  • Figure 9.3: Market Share of Biochips Products by Type, 2013
  • Figure 10.1: Toxicogenomics: DNA Microarrays
  • Figure 10.2: Microbial Genotyping: Applications for DNA Microarrays
  • Figure 11.1: Microarray Patents by Region, up to 2013
  • Figure 11.2: Microarray Patents by Year, up to 2013

INDEX OF TABLES

  • Table 2.1: Key Assay Technologies for Molecular Diagnostics
  • Table 2.2: Summary of Molecular Diagnostics Testing Sectors
  • Table 2.3: Global Market for Molecular Diagnostics Testing, 2008-2018
  • Table 2.4: Global Microarray Market, 2010-2018
  • Table 2.5: Global Market size for DNA Microarrays, 2010-2018
  • Table 2.6: Microarray Market Drivers
  • Table 2.7: Leading Microarray Companies
  • Table 2.8: Microarray Market Leaders
  • Table 4.1: List of DNA Array Manufacturers
  • Table 4.2: Steps in the Design and Implementation of a DNA Microarray Experiment
  • Table 4.3: Microarray Applications
  • Table 4.4: DNA Microarray Applications
  • Table 4.5: List of Open Source and Commercially Available Software for Microarray Analysis
  • Table 4.6: Microarray Genetic Testing
  • Table 4.7: Microarray Market Barriers
  • Table 5.1: List of Commercial Antibody Microarrays
  • Table 5.2: Commercially Available Protein Arrays
  • Table 5.3: Critical Factors for Microarray Content
  • Table 5.4: Top Suppliers of Treated Protein Microarray Surfaces for Self-Printing
  • Table 5.5: Top Suppliers of Commercially Available Protein Microarrays
  • Table 5.6: Top Suppliers of Protein Microarray Platforms
  • Table 5.7: Global Market for Protein Microarrays, 2010-2018
  • Table 6.1: Types of DNA Microarrays
  • Table 7.1: Companies Offering Cytokine Microarrays
  • Table 8.1: Comparison of Microarray Platforms
  • Table 8.2: Microarray Instruments Offered by Affymetrix
  • Table 9.1: Categories of Biochips
  • Table 9.2: Applications of Lab-on-a-Chip Technology in Industry
  • Table 9.3: Lab-on-a-Chip Diagnostics
  • Table 9.4: Lab-on-a-Chip Patents, by Region, 2013
  • Table 9.5: List of Companies with Biochip Programs
  • Table 9.6: Global Market Size for Lab-on-a-Chip, 2009-2018
  • Table 10.1: HTS Microarray Market Size Projections, 2010-2017
  • Table 10.2: Protein Microarrays in Personalized Medicine
  • Table 11.1: Main Competitors in the Microarray Market, 2013
  • Table 11.2: Microarray Patents for Selected Companies, up to 2013

INDEX OF TABLES

  • Table 2.1: Key Assay Technologies for Molecular Diagnostics
  • Table 2.2: Summary of Molecular Diagnostics Testing Sectors
  • Table 2.3: Global Market for Molecular Diagnostics Testing, 2008-2018
  • Table 2.4: Global Microarray Market, 2010-2018
  • Table 2.5: Global Market size for DNA Microarrays, 2010-2018
  • Table 2.6: Microarray Market Drivers
  • Table 2.7: Leading Microarray Companies
  • Table 2.8: Microarray Market Leaders
  • Table 4.1: List of DNA Array Manufacturers
  • Table 4.2: Steps in the Design and Implementation of a DNA Microarray Experiment
  • Table 4.3: Microarray Applications
  • Table 4.4: DNA Microarray Applications
  • Table 4.5: List of Open Source and Commercially Available Software for Microarray Analysis
  • Table 4.6: Microarray Genetic Testing
  • Table 4.7: Microarray Market Barriers
  • Table 5.1: List of Commercial Antibody Microarrays
  • Table 5.2: Commercially Available Protein Arrays
  • Table 5.3: Critical Factors for Microarray Content
  • Table 5.4: Top Suppliers of Treated Protein Microarray Surfaces for Self-Printing
  • Table 5.5: Top Suppliers of Commercially Available Protein Microarrays
  • Table 5.6: Top Suppliers of Protein Microarray Platforms
  • Table 5.7: Global Market for Protein Microarrays, 2010-2018
  • Table 6.1: Types of DNA Microarrays
  • Table 7.1: Companies Offering Cytokine Microarrays
  • Table 8.1: Comparison of Microarray Platforms
  • Table 8.2: Microarray Instruments Offered by Affymetrix
  • Table 9.1: Categories of Biochips
  • Table 9.2: Applications of Lab-on-a-Chip Technology in Industry
  • Table 9.3: Lab-on-a-Chip Diagnostics
  • Table 9.4: Lab-on-a-Chip Patents, by Region, 2013
  • Table 9.5: List of Companies with Biochip Programs
  • Table 9.6: Global Market Size for Lab-on-a-Chip, 2009-2018
  • Table 10.1: HTS Microarray Market Size Projections, 2010-2017
  • Table 10.2: Protein Microarrays in Personalized Medicine
  • Table 11.1: Main Competitors in the Microarray Market, 2013
  • Table 11.2: Microarray Patents for Selected Companies, up to 2013
Back to Top